CONCENTRATIONS	12 Months Ended
Dec. 31, 2020
CONCENTRATIONS
CONCENTRATIONS	(11) CONCENTRATIONS The Company is exposed to concentration of credit risk related primarily to its cash balances. The Company maintains its cash balances in major financial institutions that exceed amounts insured by the FDIC (up to $250,000, per financial institution as of December 31, 2020). The Company has not experienced any realized losses in such accounts and believes it is not exposed to any significant credit risk related to its cash. The Company had one major vendor from which is sourced approximately 22% and 49%, respectively, of supplies for its electrotherapy products for the years ended December 31, 2020 and 2019. Management believes that its relationships with its suppliers are good. If the relationships were to be replaced, there may be a short-term disruption for a period of time in which products may not be available and additional expenses may be incurred as the Company locates additional or replacement suppliers. The Company had receivables from one third-party payor at December 31, 2020 which made up approximately 26% of the accounts receivable balance. The Company had receivables from two third-party payors at December 31, 2019, which made up approximately 39% of the accounts receivable balance.

CONCENTRATIONS

12 Months Ended

Dec. 31, 2020

(11) CONCENTRATIONS

The Company is exposed to concentration of credit risk related primarily to its cash balances. The Company maintains its cash balances in major financial institutions that exceed amounts insured by the FDIC (up to $250,000, per financial institution as of December 31, 2020). The Company has not experienced any realized losses in such accounts and believes it is not exposed to any significant credit risk related to its cash.

The Company had one major vendor from which is sourced approximately 22% and 49%, respectively, of supplies for its electrotherapy products for the years ended December 31, 2020 and 2019. Management believes that its relationships with its suppliers are good. If the relationships were to be replaced, there may be a short-term disruption for a period of time in which products may not be available and additional expenses may be incurred as the Company locates additional or replacement suppliers.

The Company had receivables from one third-party payor at December 31, 2020 which made up approximately 26% of the accounts receivable balance. The Company had receivables from two third-party payors at December 31, 2019, which made up approximately 39% of the accounts receivable balance.